Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia |
| Full bibliographic reference | Guilhot J, Baccarani M, Clark RE, Cervantes F, Guilhot F, Hochhaus A, Kulikov S, Mayer J, Petzer AL, Rosti G, Rousselot P, Saglio G, Saussele S, Simonsson B, Steegmann JL, Zaritskey A, Hehlmann R. Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet. Blood. 2012;119(25):5963-5971. |
| Language | English |
| PubMed ID | 22508936 |
| Study design | Clinical trials, Experimental studies |
| Clinical area | Oncology |
| Applies to the whole report or to individual sections of the report? | Statistical methods and analyses, Terminology/definitions |
| Record last updated on | February 4, 2015 |